Ovarian Cancer Diagnosis and Staging by Mitchell, Donald G. et al.
UNIT A20.2Ovarian Cancer Diagnosis and Staging
The techniques used for detecting and staging ovarian cancer are similar to those used for
general imaging of the liver/abdomen and the pelvis for other applications. However, the
importance of imaging both the abdomen and pelvis, and the greater reliance on delayed
rather than early post-gadolinium images have led us to include a separate unit for imaging
patients with suspected or confirmed ovarian cancer. The authors’ experience has been
acquired primarily using GE equipment. However, the basic approach should be quite
similar, with most details relating to minor vendor-specific differences. Readers are
encouraged to read UNIT A15.2, the alternate liver unit for GE users, for general comments
on breath-holding techniques as well as the other chapters on abdominal and pelvic
imaging techniques. These, as well as the authors’ other protocols, are available on the
web at: http://www.mri.tju.edu/.
BASIC
PROTOCOL
OVARIAN CANCER
Whenever possible, patients should be triaged to MRI machines that utilize phased-array
technology to improve signal-to-noise while maintaining temporal and spatial resolution, and
have gradient and radiofrequency (RF) subsystems that are adequate in imaging large portions
of the abdomen within a single breathhold. For initial diagnosis of ovarian cancer, T1-weighted
and T2-weighted thin-slice images should be acquired with small pixel size. In the lower
pelvis, breathholding is not essential, especially on unenhanced images, but the breathhold
technique will greatly improve image sharpness above the true pelvis, especially on gadolin-
ium-enhanced images. The dynamic technique is less essential for many other applications,
but should generally be included for the liver portion of the examination to maximize
diagnostic yield and to reduce the likelihood of ambiguous findings.
The most comprehensive method for detecting and staging ovarian carcinoma begins with
high resolution T1-weighted and T2-weighted imaging of the pelvis using the torso phased
array coil. Then, the coil is moved to the abdomen for imaging the liver, including
examination with dynamic gadolinium-enhanced technique. Finally, the coil is reposi-
tioned inferiorly to obtain post-contrast imaging of the pelvis. In post-operative patients
who cannot tolerate a long examination, thicker image slices can be used for the
pre-contrast portion of the pelvic examination. This examination should require ≤1 hr.
NOTE: Be sure that technologists and nurses have immediate access to any emergency
equipment that may be relevant to a given study, or that may be needed for a particular
patient, such as crash carts or oxygen. Table A20.2.1 lists the hardware necessary to
perform the procedure, along with appropriate parameters.
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Table A20.2.1 Equipment Specifications Needed to Perform the
Imaging Sequences
Coil type Torso phased array coil
Manufacturer and system
type
GE Signa
Field strength 1.5 T
Gradient strength 25 mT/m (or whatever the system permits)
Knee cushion Yes
Pulse oximeter If patient requires sedation
Power injector Yes, if available
35-in. extension tubing Yes
Use of contrast agents Yes
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Materials
Normal saline (0.9% NaCl), sterile, 100 ml minimum
Extravascular contrast agent (e.g., Magnevist, Omniscan, or Prohance), 20 ml for
most patients
1 mg glucagon for intramuscular injection
22-G angiocatheter
Extension tubing (110-in.)
Power injector
Set up patient and equipment
1. Interview the patient to assess for contraindications such as a cardiac pacemaker,
implanted mechanical devices, and/or ferromagnetic materials. Also, determine if the
patient will need sedation medication necessitating the need for appropriate moni-
toring equipment.
Generally, standard screening forms are used for all patients scanned in a magnetic
resonance system (see APPENDIX 1).
The presence of ferromagnetic materials may be a health hazard to the patient while in the
magnetic field and/or adversely affect image quality. To determine the safety of scanning
such ferromagnetic materials, see Shellock and Kanal (1996).
The presence of ferromagnetic materials in the globe of the eye is contraindicated for MRI.
Patients with prior metal exposure to the eye should have plain X-rays of the orbital area
to ensure that all metal has been removed prior to placing them in the magnetic field. See
Shellock and Kanal (1996) for discussion of what implants may be scanned safely using
magnetic resonance.
In patients with prior surgery, metallic clips may produce artifacts that are especially
deleterious for fat-suppressed techniques. If metallic clips are present, the shortest possible
TEs should be used, and unenhanced fat-suppressed images should be examined carefullyfor areas with poor fat suppression, especially when accompanied by water suppression.
In areas such as these, a non-fat-suppressed technique should be used for the post-contrast
images.
2. If the procedure is a research protocol, have the patient sign any necessary consent
forms.
3. Instruct the patient to change into a gown and remove all personal effects, such as
jewelry, hearing aids, glasses, and other objects, prior to entering the MRI scan room.
All personal belongings should be secured during the examination.
4. Have the patient wash off any mascara and other makeup to avoid local tissue heating
and image artifacts.
5. Explain the procedure to the patient and record relevant clinical history. Ensure that
the patient understands what is expected and ask them if they have any questions;
answer appropriately.
6. Obtain intravenous (i.v.) access utilizing a 22-G angiocatheter and attach to a
saline-filled extension tubing (110-in.), with saline set to slow infusion by gravity
drip or power injector to keep the line open. Secure position of angiocatheter with
sterile clear, occlusive dressing.
Obtaining i.v. access prior to entering the scan room will promote patient throughput and
eliminate “dead” time of starting the i.v. while the patient is on the exam table. Follow
power-injector manufacturer guidelines with regard to appropriate needle gauge/angio-
catheter to be used; this will depend on chosen injection/flow rates.
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If a power injector is not accessible, dynamic imaging is still obtainable. In this case,
draw-up the contrast agent in one, 20-ml syringe and saline in two others, and flush the
timing and examination boluses. Alternatively, larger syringes can be used, drawing 20 ml
of contrast agent into one and 40 ml of saline into the other. To eliminate the need for
attaching and detaching syringes when switching from contrast to flush, incorporate the
use of a 3-way stopcock or Y-tubing.
7. Set-up the power injector as specified by the manufacturer.
A minimum of 40 ml normal saline should be drawn-up to ensure sufficient saline is
available to keep the vein open (KVO) throughout the exam. While there is no need to double
dose for hepatic MRI, a higher dose is useful for improving the conspicuity of enhanced
tissue throughout the abdomen and pelvis. The dose should be between 20 ml and 40 ml,
but we are not aware of any comparative study for this application to determine the
improvement of using >20 ml.
8. Escort the patient to the MR examination room and ask her to lie down accordingly
with respect to the exam to be performed. Connect the extension tubing secured to
the syringe to the power injector extension tubing. Review the following items with
the patient:
a. Provide earplugs or headphones to the patient to minimize the loud knocking noise
that will be produced by the gradients but ensure her that she will still be able to
hear you.
b. Provide the patient with a safety squeeze-bulb and demonstrate how it works;
explain to the patient when to use the squeeze-bulb (i.e., if she needs assistance
during the exam).
c. Explain to the patient that you will be talking to her between imaging sequences,
which will be when the loud knocking noise stops. Additionally, review breath-
holding instructions with the patient.
d. Explain to the patient that it is imperative that she remain motionless during the
imaging to ensure good results; also explain that she should not reposition her
body between imaging sequences.
e. Nevertheless, the patient may call out at any time if she feels it necessary.
f. Provide the patient with an approximate time that the examination will take.
g. Attach the power injector to the i.v., and set it to keep the vein open.
h. Inject 1 mg glucagon intramuscularly.
9. Secure the torso phased array coil to the patient, centering approximately four fingers
below the iliac crest in most patients.
While the pelvic phased array coil, if available, provides a slightly better signal-to-noise
ratio (SNR) of the pelvis than does the torso coil, the latter should be used since it can be
used for both the pelvic and abdominal portions.
Usually, straps are provided by the manufacturer that are directly attached to the coil. A
foam pad can be placed between the patient’s abdomen and the coil to reduce near-field
artifacts.
10. Place a support under the patient’s knees to enhance patient comfort.
11. Insert nasal canula for oxygen and set the flow rate to 2 liter/min, if available, to aid
in suspended respiration. A total of 2 liter of oxygen should be administered.
Hyperventilation before breath-holding is helpful. The administration of oxygen is most
helpful during the examination.
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12. Use the laser light to center the patient, at about three fingers below the iliac crests.
Advance the patient table to isocenter.
Once this step has been performed, so long as the patient does not move on the table, the
table itself can be moved and then replaced in the same position as before without
jeopardizing the positioning of one scan relative to another.
13. Program the power injector for a contrast agent and saline injection rate of 2 ml/sec.
Program the volume of saline following contrast agent injection for 20 ml. The scan
delay in healthy young patients averages 18 sec (when contrast agent is injected,
initiate scan 18 sec after contrast agent and saline are delivered), but this is highly
variable in the elderly or those with cardiovascular disease.
As indicated in the authors’ unit on liver MRI (UNIT A15.2), they strongly recommend
determination of the optimum delay in each patient. This can be done either with the
automated bolus detection (SMARTPREP) feature, or by use of a 2-ml timing bolus
sequence, as per Earls et al. (1997) and described later in this unit. Both of these methods
can be adapted to either hand or power injection.
14. Arm the power injector and keep the vein open. Do not inject the contrast agent.
Sequence 1: Coronal single-shot fast-spin echo (SSFSE)
Although some technologists precede this with a three-plane orthogonal scout sequence,
the authors find that this can be omitted safely by most experienced technologists. The
coronal single shot fast-spin echo (FSE) sequence of the pelvis is nearly always of high
quality and high information content (Fig. A20.2.1). These can be acquired using a 320
mm to 360 mm square field of view (FOV) and 5-mm image slices. The image should be
centered at or slightly below the iliac crests.
The average patient’s pelvis or abdomen can be covered in two breath-holdings, while
larger patients may require three. Adjust the number of acquisitions before pause to limit
times of suspended respiration to 20 to 25 sec. For example, if 28 slices are needed, this
can be accomplished by acquiring two sets of 14 images, with suspended respirations of
∼20 sec each. The pause between image sets should be ∼10 sec, to allow the patient to
rest between suspended respirations.
15. Instruct the patient to remain motionless, and to take a deep breath in, blow it out,
deep breath in, blow it out, and hold it. Run the sequence according to the parameters
listed in Table A20.2.2. Let the patient breathe for 10 sec, ask patient to hold her
breath, and finish running this sequence.
If a torso phased array coil is used, the kidneys are outside its optimal range. The pelvis
should be included at the bottom of the image, while at least the lower portion of the kidneys
is included at the top part of the image. Even though the kidneys are outside the optimal
range of the torso phased array coil, the images will be sufficient to verify their presence
and positions, and to detect or exclude urinary obstruction. If benign disease is diagnosed
on the pelvic examination, scanning of the abdomen may not be necessary.
16. Confirm positioning of the torso phased array coil by making certain that all parts of
the pelvis are included within the sensitive volume of the coil. Reposition and repeat
the sequence, if necessary.
Sequence 2: Transverse T2-weighted FSE for pelvis
17. Using the coronal images, position slices to ensure that the entire pelvis is covered
on transverse images, from bottom of symphysis pubis to iliac crests (Fig. A20.2.2).
Run the sequence according to the parameters listed in Table A20.2.3.
The patient should be instructed to breath quietly, with minimal body movement.
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Table A20.2.2 Imaging Parameters for Sequence 1 (Single-Shot Fast-Spin Echo)
Patient position Supine
Scan type Single-shot fast-spin echo
Imaging plane (orientation) Coronal
Variable bandwidth Yes
Pulse sequence database (PSD) ssfse
Central slice or volume center Center 3 fingers below iliac crests
Echo time (TE) 100 msec (effective)
Receiver bandwidth (RBW) ±31 kHz
Repeat time (TR) Infinite
Flip angle (FA) Default (90°)
Fields of view (FOVx, FOVy) 360 mm, 360 mm
Resolution (∆x, ∆y) 1.41 mm, 2.77 mm
Number of data points collected (Nx, Ny) 256, ∼130
Display matrix (Dx, Dy) 256, 256
Slice thickness (∆z) 5 mm
Number of slices 14 for one set (28 in total)a
Slice gap 0
Number of acquisitions (Nacq) 0.5 (half Fourier)
Swap read and phase encoding No
Slice locations A40–P40 to cover the entire pelvis
Saturation pulses None
Scan time 20 sec for one set (40 sec total)a
aSee text under sequence 1.
Figure A20.2.1 Coronal T2-weighted single-shot FSE sequence used as a localizer, with field of
view of 36 cm. White arrow indicates a cystic mass in the left adnexa. Black arrows indicate the
lower poles of the kidneys; although they are out of ideal range of the torso phased array coil, image
quality is sufficient to verify their locations and lack of collecting system dilatation.
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Figure A20.2.2 Transverse T2-weighted FSE image. Large white arrow indicates left adnexal
cystic mass, which has dependent low signal. Thin white arrow indicates the right ovary, black arrow
indicates the uterus. There is a small amount of free pelvic fluid.
Table A20.2.3 Imaging Parameters for Sequence 2 (Fast-Spin Echo)
Patient position Supine
Scan type Fast spin echo
Imaging plane (orientation) Transverse
Variable bandwidth Yes
Pulse sequence database (PSD) fse
Central slice or volume center Center to pelvis
Echo time (TE) 100 msec (effective)
Receiver bandwidth (RBW) ±31 kHz
Echo train length (ETL) 12
Repeat time (TR) 4000 msec
Flip angle (FA) Default (90°)
Fields of view (FOVx, FOVy) 200 mm, 200 mm
Resolution (∆x, ∆y) 0.78 mm, 0.78 mm
Number of data points collected (Nx, Ny) 256, 256
Display matrix (Dx, Dy) 256, 256
Slice thickness (∆z) 4 mm
Number of slices 32
Slice gap 0.5 mm
Number of acquisitions (Nacq) 2
Swap read and phase encoding Yes
Read direction Anterior–posterior
Slice location Pelvis
Saturation pulses Superior, inferior
Scan time 4 min
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Sequence 3: T1-weighted transverse spin echo
18. Obtain images as for sequence 3 according to the parameters listed in Table A20.2.4
(Fig. A20.2.3).
The patient should be instructed to breathe quietly, with minimal body movement.
19. Pull the patient out of the magnet. Reposition the torso phased array coil for imaging
the upper abdomen, centering it three fingers below the xyphoid (or switch to
abdominal portion of abdominal/pelvic coil). Send the patient into the magnet.
If abdomen is to be included, which is necessary for staging ovarian cancer, proceed to
sequence 4. If a full abdominal exam is not needed, as for a patient with a benign adnexal
mass, skip to sequence 11.
Sequence 4: Coronal single-shot FSE of abdomen
20. Run sequence 4 using a 360-mm square FOV and 5-mm slice thickness, according
to the parameters listed in Table A20.2.5.
Adjust the number of slices before running the sequence to limit times of suspended
respiration to 20 to 25 sec. For example, if 28 slices are needed, this can be accomplished
by acquiring two sets of 14 images, with suspended respirations of ∼20 sec each. The pause
between image sets should be ∼10 sec, to allow the patient to rest between suspended
respirations.
21. Instruct the patient to remain motionless, and to take a deep breath in, blow it out,
deep breath in, blow it out, and hold it. Begin acquisition. Let the patient breathe for
10 sec, ask the patient to hold her breath, and finish running the sequence.
22. Confirm positioning of the torso phased array coil by making certain that all parts of
the liver are included within the sensitive volume of the coil. Reposition and repeat
the sequence, if necessary.
Table A20.2.4 Imaging Parameters for Sequence 3 (T1-Weighted Spin Echo)
Patient position Supine
Scan type Spin echo
Imaging plane (orientation) Transverse
Variable bandwidth No
Pulse sequence database (PSD) se
Central slice or volume center Center to pelvis
Echo time (TE) 8 msec
Receiver bandwidth (RBW) ±16 kHz
Repeat time (TR) 500 msec
Flip angle (FA) Default (90°)
Fields of view (FOVx, FOVy) 200 mm, 200 mm
Resolution (∆x, ∆y) 0.78 mm, 1.04 mm
Number of data points collected (Nx, Ny) 256, 192
Display matrix (Dx, Dy) 256, 256
Slice thickness (∆z) 5 mm
Number of slices 32
Slice gap 0.5 mm
Number of acquisitions (Nacq) 2
Swap read and phase encoding Yes
Read direction Anterior–posterior
Slice location Pelvis
Saturation pulses Superior, inferior
Fat suppression No
Scan time 4 min
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Figure A20.2.3 Transverse T1-weighted spin echo image at the same level as the image in Figure
A20.2.2.
Table A20.2.5 Imaging Parameters for Sequence 4 (Single-Shot Fast-Spin Echo)
Patient position Supine
Scan type Single-shot fast-spin echo
Imaging plane (orientation) Coronal
Variable bandwidth Yes
Pulse sequence database (PSD) ssfse
Central slice or volume center Center to xyphoid
Echo time (TE) 100 msec (effective)
Receiver bandwidth (RBW) ±31 kHz
Repeat time (TR) Infinite
Flip angle (FA) Default (90°)
Fields of view (FOVx, FOVy) 360 mm, 360 mm
Resolution (∆x, ∆y) 1.41 mm, 1.88 mm
Number of data points collected (Nx, Ny) 256, ∼192
Display matrix (Dx, Dy) 256, 256
Slice thickness (∆z) 5 mm
Number of slices 14 for one set (28 in total)a
Slice gap 0
Number of acquisitions (Nacq) 0.5 (half Fourier)
Swap read and phase encoding No
Slice locations Abdomen
Saturation pulses None
Scan time 20 sec for one set (40 sec total)a
aSee annotation under step 20.
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For examples of abdominal imaging using sequences 4 through 9, please refer to UNIT A15.2,
for liver imaging.
Sequence 5: Heavily T2-weighted (TE = 180 msec) transverse single-shot FSE
23. Using the coronal images, position slices to ensure that the entire liver is covered on
transverse images. Run sequence 5 according to the parameters listed in Table
A20.2.6, during one or two suspended respirations to cover the entire abdomen.
Sequence 6: Moderately T2-weighted FSE with fat suppression
24. Prescribe the volume to cover the liver. Usually, this will require two separate,
overlapping breath-holdings. Do not obtain these as interleaved images. “Pause
before scan” must be set as “None”. Instruct the patient to remain motionless, and to
take a deep breath in, blow it out, deep breath in, blow it out, and hold it. Run the
sequence according to the parameters listed in Table A20.2.7 with 13 slices. Allow
the patient to breathe for 10 sec. Instruct the patient to hold her breath and run the
sequence with the remaining 13 slices.
25. Evaluate for image quality. This is the first motion-sensitive scan in the abdomen,
and will therefore be the first to be degraded if breath holding is not successful.
If there is substantial motion artifact, remind the patient about the importance of breath
holding, and repeat the acquisition. Consider reducing coverage or matrix, or increasing
image thickness, to reduce acquisition time if necessary.
Sequence 7: In-phase and out-of-phase transverse gradient echo
If possible, these should be obtained as a dual-echo sequence, with TEs of ∼2.3 and 4.6
msec. If this is not available, separating in-phase and opposed-phase acquisitions will be
necessary. Although the TEs mentioned are ideal, software may be configured to yield
slightly different TEs, with acceptable results.
Table A20.2.6 Imaging Parameters for Sequence 5 (Single-Shot Fast-Spin Echo)
Patient position Supine
Scan type Single-shot fast-spin echo
Imaging plane (orientation) Transverse
Variable bandwidth Yes
Pulse sequence database (PSD) ssfse
Central slice or volume center Center to liver
Echo time (TE) 180 msec (effective)
Receiver bandwidth (RBW) ±31 kHz
Repeat time (TR) Infinite
Flip angle (FA) Default (90°)
Fields of view (FOVx, FOVy) 320 mm, 240 mm
Resolution (∆x, ∆y) 1.25 mm, 2.00 mm
Number of data points collected (Nx, Ny) 256, ∼120
Display matrix (Dx, Dy) 256, 256
Slice thickness (∆z) 5 mm
Number of slices 24
Slice gap 0
Number of acquisitions (Nacq) 0.5 (half Fourier)
Swap read and phase encoding No
Slice location Abdomen
Saturation pulses None
Scan time 24 sec
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Table A20.2.7 Imaging Parameters for Sequence 6 (Fast-Spin Echo)
Patient position Supine
Scan type Fast-spin echo
Imaging plane (orientation) Transverse
Variable bandwidth Yes
Pulse sequence database (PSD) frfse-opt
Central slice or volume center Center to liver
Echo time (TE) 80 msec (effective)
Receiver bandwidth (RBW) ±62 kHz
Echo train length (ETL) 19
Repeat time (TR) 2850 msec
Flip angle (FA) Default (90°)
Fields of view (FOVx, FOVy) 320 mm, 240 mm
Resolution (∆x, ∆y) 1.25 mm, 1.67 mm
Number of data points collected (Nx, Ny) 256, ∼144
Display matrix (Dx, Dy) 256, 256
Slice thickness (∆z) 7 mm
Number of slices 26
Slice gap 0.5 mm
Number of acquisitions (Nacq) 0.5 (half Fourier)
Swap read and phase encoding No
Slice location Cover the liver
Saturation pulses Superior, inferior
Fat suppression Yes
Scan time 46 sec
Table A20.2.8 Imaging Parameters for Sequence 7 (Gradient Echo)
Patient position Supine
Scan type 2-D double-gradient echo
Imaging plane (orientation) Transverse
Variable bandwidth Yes
Pulse sequence database (PSD) fgre-dual
Central slice or volume center Center to liver
Echo time (TE) 2.3 msec and 4.6 msec
Receiver bandwidth (RBW) ±62 kHz
Repeat time (TR) 200 msec
Flip angle (FA) 90°
Fields of view (FOVx, FOVy) 320 mm, 240 mm
Resolution (∆x, ∆y) 1.25 mm, 3.00 mm
Number of data points collected (Nx, Ny) 256, ∼80
Display matrix (Dx, Dy) 256, 256
Slice thickness (∆z) 5 mm
Number of slices 24
Slice gap 0
Number of acquisitions (Nacq) 0.5 (half Fourier)
Swap read and phase encoding No
Slice location Cover the liver
Saturation pulses Superior, inferior
Scan time 24 sec
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26. Position slices to cover entire liver and adjust levels if necessary. Instruct the patient
to remain motionless, and to take a deep breath in, blow it out, deep breath in, blow
it out, and hold it. Run sequence 7 according to the parameters listed in Table A20.2.8.
Sequence 8: Timing bolus sequence (if SMARTPREP is not used)
If SMARTPREP is used, skip steps 27 and 28; a timing bolus sequence is not needed.
27. Inject 2 ml of gadolinium chelate of 2 ml/sec, followed immediately by a 20-ml flush
of saline (Earls et al., 1997).
The size of the syringe used should be the same as that used for injecting the bolus of
gadolinium chelate, and the speed of injection should be as identical as possible.
28. Begin image acquisition at the beginning of the flush, according to the parameters
listed in Table A20.2.9. Breath-holding is not necessary.
The aorta will have low signal intensity on all of these images, until the 2-ml bolus of
gadolinium arrives, at which point there will be a noticeable increase in aortic signal
intensity. The time after the beginning of the acquisition is annotated in the upper left hand
corner of the image as the delay time (DT), and can also be determined by noting the image
number and multiplying by 1 sec.
If the acquisition of the sequence begins when the flush begins, when signal intensity peaks
in the mid aorta, the delay time is the time it takes an injection of the contrast agent to
travel from the i.v. tubing port to the abdominal aorta. This should correspond to the delay
time between beginning the major gadolinium bolus and beginning the acquisition. For
example, if it takes 25 sec for the gadolinium to travel from the i.v. tubing port to the
mid-abdominal aorta, breathholding instructions should be given so that the actual pulse
sequence begins 25 sec following the beginning of the gadolinium injection.
29. Set up SMARTPREP region of interest, if SMARTPREP is used. This should cover
the upper abdominal aorta on the coronal scout image obtained from sequence 1, at
the level of the upper poles of the kidneys. It should be 50 mm long by 20 mm wide.
The trigger should be set for a 20% increase in intensity, with a 7-sec delay to allow
breathholding instructions.
Sequence 9: Dynamic multi-phasic pre/post 3-D short TR gradient echo (liver)
30. Prescribe the volume to cover the liver. TR and TE should be as short as possible, and
flip angle should be 12° to 15°. Instruct the patient to remain motionless, and to take
a deep breath in, blow it out, deep breath in, blow it out, and hold it. Run the sequence
according to the parameters listed in Table A20.2.10 but with a certain number of
slices such that the scan time is ∼20 sec. Allow the patient to breathe and move the
region of interest to the next slab. Instruct the patient to hold her breath again and
continue to run the sequence. Repeat this procedure until the entire region of interest
is covered.
There will be visible contrast in the kidneys and collecting systems if a timing bolus was
used, but there will be no significant effect on any other tissues.
31. Explain to the patient that the contrast agent will be injected and that she may feel a
cool sensation in her arm. Initiate the injection. Do not begin scanning until the scan
delay has expired. However, breathing instructions should be initiated when ∼5 sec
of delay remain.
If access to a power injector is not available and are manual injecting, reattach the
saline-filled syringe and flush with 20 ml of saline. The process of switching syringes must
be completed as quickly as possible and thus, the suggestion of incorporating the use of a
3-way stopcock.
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Table A20.2.9 Imaging Parameters for Sequence 8 (Timing Bolus)
Patient position Supine
Scan type Gradient echo
Imaging plane (orientation) Sagittal
Variable bandwidth No
Pulse sequence database (PSD) fspgr
Central slice or volume center Upper abdominal aorta
Echo time (TE) Minimum (∼2 msec)
Receiver bandwidth (RBW) ±16 kHz
Repeat time (TR) 7 msec
Flip angle (FA) 70°
Fields of view (FOVx, FOVy) 320 mm, 240 mm
Resolution (∆x, ∆y) 1.25 mm, 2.50 mm
Number of data points collected (Nx, Ny) 256, 96
Display matrix (Dx, Dy) 256, 256
Slice thickness (∆z) 20 mm
Number of slices 1
Slice gap N/A
Number of acquisitions (Nacq) 1
Swap read and phase encoding No
Slice location Upper abdominal aorta
Saturation pulses None
Multi-phase 60
Scan time 50 sec
Table A20.2.10 Imaging Parameters for Sequence 9 (Dynamic 3-D Gradient
Echo)
Patient position Supine
Scan type 3-D gradient echo
Imaging plane (orientation) Transverse
Variable bandwidth Yes
Pulse sequence database (PSD) lufgre3d
Central slice or volume center Center to liver
Echo time (TE) Minimum (∼1.5 msec)
Receiver bandwidth (RBW) ±62 kHz
Repeat time (TR) 4 msec
Flip angle (FA) 12°to 15°
Fields of view (FOVx, FOVy) 320 mm, 240 mm
Resolution (∆x, ∆y) 1.25 mm, 3.00 mm
Number of data points collected (Nx, Ny) 256, ∼80
Display matrix (Dx, Dy) 256, 256
Slice thickness (∆z) 5 mm
Number of slices 192
Slice gap −2.5 mm (overlap)
Number of acquisitions (Nacq) 0.5 (half Fourier)
Swap read and phase encoding No
Slice location Cover the liver
ZIP2 Yes
Saturation pulses None
Fat suppression Yes, spectral inversion at lipids
(SPECIAL)
Scan time 72 sec
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Figure A20.2.4 In a different patient, with history of ovarian cancer, 2-D fat-suppressed short TR
gradient echo images with TR/TE = 19/2 msec, and 30° flip angle, ∼5 min after gadolinium chelate
injection. Arrows indicate solid enhancing perihepatic tissue consistent with peritoneal metastases.
Table A20.2.11 Imaging Parameters for Sequence 10 (Fat-Suppressed Gradient
Echo)
Patient position Supine
Scan type 2-D gradient echo
Imaging plane (orientation) Transverse
Variable bandwidth No
Pulse sequence database (PSD) fspgr
Central slice or volume center Center to liver
Echo time (TE) Minimum (∼2 msec)
Receiver bandwidth (RBW) ±16 kHz
Repeat time (TR) 19 msec
Flip angle (FA) 30°
Fields of view (FOVx, FOVy) 320 mm, 240 mm
Resolution (∆x, ∆y) 1.25 mm, 2.0 mm
Number of data points collected (Nx, Ny) 256, 120
Display matrix (Dx, Dy) 256, 256
Slice thickness (∆z) 5 mm
Number of slices ∼30
Slice gap 0
Number of acquisitions (Nacq) 1
Swap read and phase encoding No
Slice location Entire liver
Fat suppression Yes
Scan time ∼60 sec
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32. Obtain the first set of post-contrast images as soon as possible according to Table
A20.2.10. Repeat step 30. Allow the patient ∼5 sec rest between the first and second
post-contrast acquisitions. Repeat step 30 again and obtain a second set of post-con-
trast acquisitions. It is best to observe the patient’s respirations on the screen to verify
that she is suspending respirations successfully when directed.
Sequence 10: 2-D transverse gradient echo with fat suppression (Fig. A20.2.4)
33. Instruct the patient to remain motionless, and to take a deep breath in, blow it out,
deep breath in, blow it out, and hold it. Run sequence 10 according to the parameters
listed in Table A20.2.11 but with a certain number of slices such that the scan time
is ∼20 sec. Allow the patient to breathe and move the region of interest to the next
slab. Instruct the patient to hold her breath again and continue to run the sequence.
Repeat this procedure until the entire region of interest is covered.
A
B C
Figure A20.2.5 3-D fat-suppressed short TR gradient echo images before (A), immediately after (B), and 45 sec after (C)
gadolinium chelate injection. Through Fourier interpolation, images are reconstructed every 2.5 mm. Large arrow in A
indicates the left adnexal cyst, small arrows indicate dependent increased signal intensity. Arrows in C indicate uniform
thickness of the enhancing wall of the cyst, without solid or nodular enhancement to suggest tumor. Findings are most
compatible with a benign hemorrhagic cyst.
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TR should be ∼20 msec. These images show delayed extracellular space contrast, and all
vessels are white because of the combined effects of gadolinium and time-of-flight. Motion
artifact is minimal because the short TR allows completion of each image in <2 sec. These
should be obtained as several stacks of overlapping slices, to ensure that the fat suppression
is adjusted properly for the volume of interest. The upper- and mid-abdomen should be
imaged without significant gaps between image stacks.
Sequence 11: Dynamic 3-D short TR gradient echo (pelvis)
If an abdominal examination is not included, such as if the pelvic images are not
suggestive of ovarian cancer, the dynamic multi-phasic examination should be modified
for imaging of the pelvis (Fig. A20.2.5).
34. Pull the patient out of the magnet. Reposition torso phased array coil for pelvis (or
switch to pelvic portion of abdominal/pelvic coil). Center the patient and advance
the patient into the magnet.
35. Repeat step 30 (with the coverage of pelvis) but run sequence 11 according to the
parameters in Table A20.2.12. This involves the use of smaller field of view. If desired,
slice thickness can be reduced. A timing bolus is generally not used for pelvic
imaging. Obtain three sets of post-contrast images. The procedures are similar to
those in steps 31 and 32.
Although dynamic scanning is less important for imaging the adnexa than for imaging the
abdomen, vessels and some tissues may be defined better. Next, sequence 12 should be
obtained.
Table A20.2.12 Imaging Parameters for Sequence 11 (Dynamic 3-D Gradient
Echo)
Patient position Supine
Scan type 3-D gradient echo
Imaging plane (orientation) Transverse
Variable bandwidth Yes
Pulse sequence database (PSD) lufgre3d
Central slice or volume center Center to pelvis
Echo time (TE) Minimum (∼1.5 msec)
Receiver bandwidth (RBW) ±62 kHz
Repeat time (TR) 4 msec
Flip angle (FA) 12°to 15°
Fields of view (FOVx, FOVy) 240 mm, 240 mm
Resolution (∆x, ∆y) 0.94 mm, 2.82 mm
Number of data points collected (Nx, Ny) 256, ∼85
Display matrix (Dx, Dy) 256, 256
Slice thickness (∆z) 5 mm
Number of slices 256
Slice gap −2.5 mm
Number of acquisitions (Nacq) 0.5 (half Fourier)
Swap read and phase encoding No
Slice location Pelvis
ZIP 2 Yes
Saturation pulses None
Fat suppression Yes, spectral inversion at lipids
(SPECIAL)
Scan time 96 sec
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Figure A20.2.6 In the same patient as in Figures A20.2.1 to A20.2.4, 2-D sagittal fat suppressed
short TR gradient echo images with TR and TE = 19/2 msec, and 30° flip angle, about five minutes
after gadolinium chelate injection. The cyst wall and surrounding tissues enhance, but there is no
internal enhancement.
Table A20.2.13 Imaging Parameters for Sequence 12 (Fat-Suppressed Gradient
Echo)
Patient position Supine
Scan type 2-D gradient echo
Imaging plane (orientation) Transverse or sagittal
Variable bandwidth No
Pulse sequence database (PSD) fspgr
Central slice or volume center Center to pelvis
Echo time (TE) Minimal (∼2 msec)
Receiver bandwidth (RBW) ±16 kHz
Repeat time (TR) 19 msec
Flip angle (FA) 30°
Fields of view (FOVx, FOVy) 240 mm, 240 mm
Resolution (∆x, ∆y) 0.94 mm, 1.88 mm
Number of data points collected (Nx, Ny) 256, 128
Display matrix (Dx, Dy) 256, 256
Slice thickness (∆z) 5 mm
Number of slices ∼30
Slice gap 0
Number of acquisitions (Nacq) 1
Swap read and phase encoding No
Slice location Pelvis
Fat suppression Yes
Scan time ∼60 sec
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Sequence 12: 2-D transverse or sagittal gradient echo with fat suppression (Fig.
A20.2.6)
36. Instruct the patient to remain motionless, and to take a deep breath in, blow it out,
deep breath in, blow it out, and hold it. Cover the pelvis, and run sequence 12
according to the parameters in Table A20.2.13 but with a certain number of slices
such that the scan time is ∼20 sec. Allow the patient to breathe and move the region
of interest to the next slab. Instruct the patient to hold her breath again and continue
to run the sequence. Repeat this procedure until the entire region of interest is covered.
COMMENTARY
Background Information
A comprehensive protocol for imaging the
abdomen and pelvis in women with ovarian
cancer that includes in-phase and out-of-phase
T1-weighted images, moderately and heavily
T2-weighted, and early and late post-gadolin-
ium images is described in this unit. Each ab-
dominal sequence is acquired in one or two
breath-holds, while un-enhanced T1-weighted
and T2-weighted images are non-breath-hold
and are used in the pelvis. It is possible that
comparable or better image quality can be ob-
tained using an entirely breath-hold protocol,
but the authors have retained the longer se-
quences in the pelvis to ensure high spatial
resolution and SNR. If the initial pelvic images
and/or patient history are not strongly sugges-
tive of ovarian cancer, staging is unnecessary,
and the abdominal portion of the examination
may be omitted, as described above.
The most important pulse sequence for di-
agnosing and staging ovarian carcinoma is the
delayed fat-suppressed post-gadolinium se-
quence. In cooperative patients, thinner over-
lapping slices with higher SNR can be obtained
by using the fast 3-D short TR gradient echo
sequence (efgre3d or lufgre3d in the GE ma-
chine). However, these images are more mo-
tion-sensitive, and do not depict blood vessels
as well, compared to the single-slice 2-D se-
quences described here.
Critical Parameters and
Troubleshooting
The two major potential problems with this
protocol are that, for the abdominal portion,
patients may not be able to suspend respiration
or timing of gadolinium administration may be
incorrect. The first problem can be addressed
by substituting short TR (≤10 msec) single-slice
2-D gradient echo T1-weighted sequences with
a flip angle of ∼30°. The second problem is
prevented in most cases by using a test dose of
gadolinium to determine timing (Earls et al.,
1997), or by using an automated detection
method such as SMARTPREP. If abdominal
images are not acquired, the timing of gadolin-
ium injection is not critical; the delayed post-
gadolinium images are most important.
Another problem occurs in patients with
implanted metal, such as from surgical clips.
Artifacts from metal on gradient echo images
can be minimized by using the shortest possible
TE, avoiding fat suppression, and increasing the
number of acquisitions (Nacq) or number of
excitations (NEX) from 0.5 to 1.0. TE on the
3-D-short TR gradient echo sequence is mini-
mized by increasing the sampling bandwidth
from ±31 to ±62 KHz. The acquisition time will
be slightly longer, so adjustments in number of
image slices and/or acquisition matrix may be
necessary.
Anticipated Results
Most reports comparing MRI and computed
tomography (CT) indicate that MRI is superior
for depicting normal and abnormal gyne-
cologic anatomy, and for distinguishing be-
tween benign and malignant adnexal and he-
patic masses. Importantly, proper use of gad-
olinium and fat suppression leads to a higher
sensitivity of MRI for detecting small perito-
neal implants from ovarian carcinoma.
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